Published in Blood on July 01, 1970
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified 987 or K99 pili: protection correlates with pilus homology of vaccine and challenge. Infect Immun (1978) 2.52
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol (1993) 2.04
Cross-reaction of anti-lymphocyte serum with haemopoietic stem cells. Nature (1968) 1.97
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
Mode of action of the cytostatic agent "ICRF 159". Nature (1970) 1.75
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl (1980) 1.44
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer (1980) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer (1979) 1.30
The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28
Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer (1984) 1.25
Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified K99 or 987P pili: antibody production in response to vaccination. Infect Immun (1980) 1.25
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer (1985) 1.24
Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24
Survival in 6086 cases of bronchial carcinoma. Lancet (1967) 1.23
Testicular tumours. Clin Endocrinol Metab (1975) 1.20
Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17
Children fathered by men treated for testicular cancer. Lancet (1985) 1.16
Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15
Results of treating primary tumours of the trachea by irradiation. Thorax (1978) 1.15
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol (1989) 1.14
Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol (1989) 1.13
Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. Lancet (1972) 1.13
VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer (1980) 1.13
Combination chemotherapy for testicular tumours. Proc R Soc Med (1974) 1.13
Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy. J Natl Cancer Inst (1970) 1.13
Hodgkin's disease. II. Br Med J (1967) 1.12
The management of metastatic seminoma testis. Cancer (1982) 1.12
Radiation therapy of the non-Hodgkin's lymphomas. Semin Hematol (1974) 1.09
The response of lymph node metastases of testicular teratoma to radiation therapy. Br J Urol (1976) 1.09
Human tumour xenografts: a critical appraisal. Br J Cancer Suppl (1980) 1.08
Factors influencing survival in patients with Hodgkin's disease. Clin Radiol (1969) 1.07
Maturation in human tumours. Lancet (1969) 1.07
The results of radiotherapy for Hodgkins' disease. Br J Cancer (1975) 1.06
Radiosensitivity of the acute leukaemic infiltrate. Eur J Cancer (1976) 1.06
Research and ophthalmology in the UK. Lancet (1990) 1.06
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer (1980) 1.05
Effects of thymectomy and irradiation on graft-versus-host disease. Transplantation (1965) 1.05
Combination chemotherapy for small cell carcinoma of the lung. Cancer (1977) 1.04
Combined radiotherapy--chemotherapy of Lewis lung carcinoma. Int J Radiat Oncol Biol Phys (1978) 1.04
Occult germ-cell testicular tumours. Br J Urol (1983) 1.04
Effect of thalidomide on the graft versus host reaction. Nature (1966) 1.02
Clinical assessment of growth-rate in human tumours. Clin Radiol (1968) 1.02
Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol (1983) 1.01
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement. Br J Cancer (1987) 1.01
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. Eur J Cancer (1968) 1.00
Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma. Cancer Treat Rep (1985) 0.99
Radiotherapy for stage I seminoma testis: results of treatment and complications. Radiother Oncol (1986) 0.99
Radiation cancer of the pharynx. Case reports. Acta Radiol Ther Phys Biol (1965) 0.98
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. Cancer (1976) 0.98
Serum-alpha1-fetoprotein in patients with testicular tumours. Lancet (1976) 0.97
Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. Radiother Oncol (1987) 0.97
A human testicular teratoma serially transplanted in immune-deprived mice. Br J Cancer (1979) 0.97
A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft. Eur J Cancer (1979) 0.97
Alcohol pain in Hodgkin's disease. Cancer (1976) 0.97
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. J Clin Oncol (1991) 0.97
Treatment of carcinoma of the thyroid with radioiodine. Br Med J (1965) 0.97
Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour. Br J Cancer (1979) 0.96
Bilateral germ cell tumours of the testis. Br J Urol (1980) 0.96
Reduced sensitivity of F-1 hybrid rats to re-challenge with parental strain spleen cells. Clin Exp Immunol (1966) 0.96
Hodgkin's disease: one entity or two? Lancet (1970) 0.96
The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol (1977) 0.94
Chemotherapy for metastatic teratomas of the testis. Br J Urol (1972) 0.94
The radiobiology of human neuroblastoma. Radiother Oncol (1985) 0.93
Orchidectomy alone for stage I seminoma of the testis. Cancer (1990) 0.93
Postchemotherapy staging laparotomy in Hodgkin's disease. Br J Cancer (1982) 0.92
In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. Br J Cancer (1982) 0.92
The role of surgery in the combined management of metastases from malignant teratomas of testis. Br J Urol (1987) 0.92
Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol (1993) 0.91
Fertility after unilateral orchidectomy and radiotherapy for patients with malignant tumours of the testis. Br Med J (1973) 0.90
Lung damage in C57B1 mice following thoracic irradiation: enhancement by chemotherapy. Br J Radiol (1979) 0.90
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. Br J Cancer (1982) 0.90